Andrew P Rasdal Insider Trading $OBLN ReShape Lifesciences Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew P Rasdal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew P Rasdal. Andrew P Rasdal is President & CEO in DEXCOM INC ($DXCM) and CEO in OBALON THERAPEUTICS INC ($OBLN) and Exec Chairman of the Board in OBALON THERAPEUTICS INC ($OBLN) and President & CEO in OBALON THERAPEUTICS INC ($OBLN) and President, CEO & Exec Chairman in OBALON THERAPEUTICS INC ($OBLN).
Andrew P Rasdal in ReShape Lifesciences Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Andrew P Rasdal: President, CEO & Exec Chairman, Exec Chairman of the Board, President & CEO
Holdings: 77,892 shares
Current Value: $744,648
Latest Transaction: Jun 25 2020
$OBLN Market Capitalization: $158.66M
$OBLN Previous Close: $9.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Andrew P Rasdal in ReShape Lifesciences Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2020 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | President, CEO & Ex ... | Option Exercise | A | 0.73 | 165,135 | 120,549 | 165,135 | |
| Jun 25 2020 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | President, CEO & Ex ... | Option Exercise | A | 0.00 | 52,865 | 0 | 52,865 | |
| Aug 08 2019 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | Exec Chairman of th ... | Option Exercise | P | 4.40 | 9,375 | 41,250 | 9,375 | |
| Aug 08 2019 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | Exec Chairman of th ... | Buy | P | 4.00 | 12,500 | 50,000 | 77,892 | 65.4 K to 77.9 K (+19.12 %) |
| Jan 04 2019 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | Exec Chairman of th ... | Grant | A | 0.00 | 86,957 | 0 | 653,905 | 566.9 K to 653.9 K (+15.34 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | CEO | Grant | A | 1.82 | 109,890 | 200,000 | 566,948 | 457.1 K to 566.9 K (+24.04 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | CEO | Grant | A | 1.82 | 109,890 | 200,000 | 566,948 | 457.1 K to 566.9 K (+24.04 %) |
| May 02 2018 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | President & CEO | Grant | A | 3.27 | 2,987 | 9,767 | 457,058 | 454.1 K to 457.1 K (+0.66 %) |
| Nov 02 2017 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | President & CEO | Grant | A | 7.17 | 808 | 5,793 | 454,071 | 453.3 K to 454.1 K (+0.18 %) |
| May 02 2017 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | President & CEO | Grant | A | 9.03 | 2,768 | 24,995 | 453,263 | 450.5 K to 453.3 K (+0.61 %) |
| Nov 14 2016 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | President & CEO | Option Exercise | A | 8.74 | 300,000 | 2,622,000 | 300,000 |
Page: 1